OrCam Technologies

Category: Target

Israeli AI assistive technology company developing wearable devices for visually and hearing impaired individuals, founded by Mobileye creators in Jerusalem

HQ: Israel Website Updated: 6 Jan 2026

Take Action

Apply pressure where it matters. Use these tools and personalise your message with evidence from this page.

Before taking action, review our Code of Conduct for professional standards and ethical guidelines.

Share this company Ready-written posts for every platform, from the evidence on this page.

LinkedIn

For professional networks: buyers, investors, colleagues.

X and Bluesky thread

Numbered posts, each under 280 characters. Post the first, then the rest as replies.

Instagram and Facebook

A caption to post with the share card or an evidence card.

WhatsApp and messages

A short message to send to friends or colleagues.

Help Us Hold OrCam Technologies Accountable

Your skills and knowledge can strengthen this campaign. Join our volunteer research team or share insider information securely.

Leverage Your Expertise

Do you work in this sector? We need professionals who understand procurement cycles, regulatory compliance, and corporate governance. Don't just boycott - lead!

Decision-Maker Directory

Key individuals with influence over corporate partnerships and procurement decisions. The contact details shown are published business addresses, listed for professional correspondence only. Write to the role, not the person, and keep correspondence courteous and factual. Repeated, abusive or personal contact is unlawful harassment and damages the case being made.

Prof. Amnon Shashua
Co-founder & CEO
Also founder of Mobileye; received Israel Prize 2023; Hebrew University professor
Public contact: Via corporate website or press inquiries
Ziv Aviram
Co-founder & President
Also co-founded Mobileye; manages business operations
Public contact: Via corporate website

Material Risk Framing

Frame your message around business risks. These talking points resonate with corporate stakeholders and institutional investors.

Legal & Compliance

Medical/assistive device regulations provide some protection; no documented military applications or surveillance technology

Financial & Investor

Private company with unicorn valuation ($1B+ since 2018); significant venture capital backing; limited public financial disclosure

Reputational & Brand

Assistive technology positioning creates ethical complexity; targeting disabled users complicates boycott messaging

Operational & Supply Chain

B2B distribution through medical and accessibility channels; partnerships with disability organisations globally

Strategic Analysis

In-depth assessment of the company's position, vulnerabilities, and recommended approaches for effective engagement.

Severity → Strategic vulnerability →
Target

Lower severity, high vulnerability: momentum builders that fold quickly

Severity
5.0/10
Strategic vulnerability
6.0/10

Learn about our methodology. Companies are categorised based on severity (harm potential) vs strategic vulnerability (campaign leverage).

Why do these scores change?

Unlike static boycott lists, our targeting model is dynamic. This company's position on the matrix is re-evaluated continually as we verify new contracts, divestments, or policy changes. Your reporting directly impacts this score.

OrCam Technologies presents a strategically complex boycott target. As an Israeli-headquartered AI company founded by Mobileye creators Amnon Shashua and Ziv Aviram, OrCam contributes to the Israeli technology ecosystem and economy. However, the company's focus on assistive technology for visually and hearing impaired individuals creates significant ethical complexity that distinguishes it from other Israeli technology firms.

Key Leverage Points

  • Israeli Economic Contribution: Unicorn-status company headquartered in Israel, contributing tax revenue and reinforcing Israel's technology reputation
  • Founder Network: Same founders as Mobileye creates connection to Intel acquisition proceeds and broader Israeli tech ecosystem
  • B2B Healthcare Distribution: Distribution through medical and accessibility channels enables institutional procurement pressure
  • Private Company Status: Limited public disclosure and no public shareholders reduces investor pressure avenues

Ethical Considerations

OrCam's assistive technology focus creates genuine ethical tension for boycott campaigns. The OrCam MyEye device provides meaningful independence to blind and visually impaired individuals, enabling them to read text, recognise faces, and navigate environments. Unlike surveillance technology or military applications, OrCam's products directly serve vulnerable populations. Campaigns targeting OrCam must carefully consider the impact on disabled users who may have limited alternatives. This does not negate the company's contribution to the Israeli economy, but should inform messaging and prioritisation.

Engagement Strategy

Given the ethical complexity, OrCam should be treated as a monitoring target rather than an active campaign priority. Document the company's Israeli economic contribution and founder connections to Mobileye/Intel. Engage disability advocacy organisations to develop nuanced positions that acknowledge both Palestinian rights and accessibility needs. Focus institutional pressure on healthcare procurement policies while ensuring disabled users are not disproportionately affected. Prioritise higher-impact targets with clearer military, surveillance, or occupation connections before escalating OrCam campaigns.

Evidence & Sources

Verified sources including NGO reports, regulatory filings, and primary documents. Use these to substantiate your correspondence. Entries marked First-hand were reported directly to this site and are published without identifying the source.

30 Oct 2024 News TIME Best Inventions 2024

OrCam continues recognition as leading accessibility technology innovator

Open source
1 Jan 2024 Corporate Statement OrCam About Page

Confirms Jerusalem founding in 2010 by Mobileye co-founders Amnon Shashua and Ziv Aviram

Open source
26 Apr 2023 News Amnon Shashua Receives Israel Prize

OrCam CEO receives Israel's highest honour for contributions to technology and enterprise

Open source
21 Nov 2019 News TIME Best Inventions 2019

OrCam MyEye named to TIME's list of best inventions for accessibility innovation

Open source
21 Feb 2018 News OrCam Reaches Unicorn Status

Company achieves $1 billion valuation following Series B funding round

Open source

Updates & Milestones

2024
Oct
TIME Best Inventions 2024

Continued recognition for accessibility innovation

2023
Apr
Israel Prize Awarded

CEO Amnon Shashua receives Israel Prize for technology contributions

2021
2021
TIME Recognition Continues

OrCam products again featured in TIME's Best Inventions list

2019
Nov
TIME Best Inventions

OrCam MyEye named to TIME's Best Inventions 2019 list

2018
Feb
Unicorn Valuation

OrCam achieves $1 billion+ valuation following Series B funding round

2015
2015
OrCam MyEye Launch

First commercial product released - wearable AI device for visually impaired users

2010
2010
Company Founded

Amnon Shashua and Ziv Aviram found OrCam Technologies in Jerusalem, applying AI to assistive technology

Disclaimer: All information on this page is published in the public interest, based on good-faith research from credible sources and aligned with the UN Guiding Principles on Business & Human Rights. Companies and individuals may request corrections or page removal via our Feedback Form.